Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Sheets

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|August 5, 2008
An overview of animal cell substrates for biological productsJohn Petricciani, Rebecca Sheets
Vaccine|March 10, 2015
WHO consultation on clinical evaluation of vaccines, 17-18 July 2014, WHO Headquarters, Geneva, SwitzerlandIvana Knezevic, Vasee Moorthy, Rebecca Sheets
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2012
Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MDRebecca Sheets, Johannes Loewer, Gopa Raychaudhuri, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 20, 2014
Adventitious agents in viral vaccines: lessons learned from 4 case studiesJohn Petricciani, Rebecca Sheets, Elwyn Griffiths, et al.
NPJ Vaccines|June 25, 2020
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019Rebecca Sheets, Hye-Na Kang, Heidi Meyer, et al.
Current HIV/AIDS Reports|August 11, 2005
Current advances in HIV vaccinesM Patricia D'Souza, Mary Allen, Rebecca Sheets, et al.
Biologicals : Journal of the International Association of Biological Standardization|December 1, 2012
Potential use of inflammation and early immunological event biomarkers in assessing vaccine safetyBéatris Mastelic, David J M Lewis, Hana Golding, et al.
Vaccine|June 19, 2016
Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisBettina Klug, James S Robertson, Richard C Condit, et al.
Vaccine|June 28, 2016
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strainsRichard C Condit, Anna-Lise Williamson, Rebecca Sheets, et al.
Vaccine|October 12, 2014
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)Robert T Chen, Baevin Carbery, Lisa Mac, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biologicals : Journal of the International Association of Biological Standardization|August 5, 2008
An overview of animal cell substrates for biological productsJohn Petricciani, Rebecca Sheets
Vaccine|March 10, 2015
WHO consultation on clinical evaluation of vaccines, 17-18 July 2014, WHO Headquarters, Geneva, SwitzerlandIvana Knezevic, Vasee Moorthy, Rebecca Sheets
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2012
Adventitious agents, new technology, and risk assessment, 19-20 May 2011, Baltimore, MDRebecca Sheets, Johannes Loewer, Gopa Raychaudhuri, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 20, 2014
Adventitious agents in viral vaccines: lessons learned from 4 case studiesJohn Petricciani, Rebecca Sheets, Elwyn Griffiths, et al.
NPJ Vaccines|June 25, 2020
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019Rebecca Sheets, Hye-Na Kang, Heidi Meyer, et al.
Current HIV/AIDS Reports|August 11, 2005
Current advances in HIV vaccinesM Patricia D'Souza, Mary Allen, Rebecca Sheets, et al.
Biologicals : Journal of the International Association of Biological Standardization|December 1, 2012
Potential use of inflammation and early immunological event biomarkers in assessing vaccine safetyBéatris Mastelic, David J M Lewis, Hana Golding, et al.
Vaccine|June 19, 2016
Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisBettina Klug, James S Robertson, Richard C Condit, et al.
Vaccine|June 28, 2016
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strainsRichard C Condit, Anna-Lise Williamson, Rebecca Sheets, et al.
Vaccine|October 12, 2014
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)Robert T Chen, Baevin Carbery, Lisa Mac, et al.
Pageof 2